Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0039730 (
thalassemia
)
10,305
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
SKIP
has been described as a transcriptional coregulator as well as a spliceosome component, but the relationship between these functions is not clear. We found that
SKIP
activated reporter gene expression from the basal promoters of viral origin.
SKIP
exhibited more prominent effect on the promoters with stronger activities, in an experiment employing a series of reporter constructs carrying different numbers of GC boxes. We also found that
SKIP
suppressed aberrant splicing at a cryptic splice donor site in the luciferase reporter gene. In addition,
SKIP
suppressed splicing of an extra intron created by a beta-
thalassemia
mutation in the human beta-globin gene. In the transfection experiment, an intronless reporter exhibited a higher level of expression, but was less significantly activated by
SKIP
, than the intron-containing reporter. These results indicate that
SKIP
affects gene expression by both transcriptional activation and regulation of pre-mRNA splicing.
...
PMID:SKIP modifies gene expression by affecting both transcription and splicing. 1502 Feb 46